TABLE 1.
Univariate and multivariate Cox analyses of the m6A-GSVS and routine clinicopathologic characteristics in patients with lung adenocarcinomas.
| Characteristic | Univariate Cox analysis |
Multivariate Cox analysis |
||||||
| β | HR | HR (95%CI) | P value | β | HR | HR (95%CI) | P value | |
| Gender | ||||||||
| Male | ref. | |||||||
| Female | 0.060 | 1.061 | 0.793–1.420 | 0.689 | ||||
| Age | 0.009 | 1.009 | 0.994–1.024 | 0.259 | ||||
| Primary tumor (T) | ||||||||
| T1–2 | ref. | |||||||
| T3–4 | 0.861 | 2.366 | 1.622–3.451 | 0.000 | 0.671 | 1.956 | 1.281–2.986 | 0.002 |
| Tx | 1.284 | 3.611 | 0.887–14.693 | 0.073 | 1.135 | 3.112 | 0.411–23.557 | 0.272 |
| Lymph nodes (N) | ||||||||
| N0 | ref. | |||||||
| N1–3 | 0.957 | 2.605 | 1.938–3.500 | 0.000 | 0.846 | 2.331 | 1.638–3.315 | 0.000 |
| Nx/Not available | 0.479 | 1.615 | 0.592–4.409 | 0.995 | 0.127 | 1.136 | 0.279–4.629 | 0.859 |
| Metastases (M) | ||||||||
| M0 | ref. | |||||||
| M1 | 0.731 | 2.077 | 1.214–3.553 | 0.008 | 0.318 | 1.374 | 0.742–2.546 | 0.312 |
| Mx/Not available | −0.174 | 0.841 | 0.587–1.204 | 0.344 | −0.074 | 0.929 | 0.647–1.335 | 0.691 |
| Pathological stage | ||||||||
| I-II | ref. | |||||||
| III-IV | 0.962 | 2.618 | 1.921–3.567 | 0.000 | 0.160 | 1.174 | 0.757–1.819 | 0.474 |
| Not available | −0.370 | 0.691 | 0.170–2.800 | 0.604 | −0.519 | 0.595 | 0.146–2.425 | 0.469 |
| m6A GSVS | 0.820 | 2.270 | 1.192–4.324 | 0.013 | 0.939 | 2.559 | 1.310–4.998 | 0.006 |
HR, hazard ratio; CI, confidence interval; ref., reference; m6A-GSVS, m6A-related gene set variation score. Bold values p represent <0.05.